|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization of premiums and discounts on available-for-sale securities | |||||
| Depreciation and amortization of fixed assets | |||||
| Non-cash operating lease cost | |||||
| Write-down of inventory | |||||
| Loss on extinguishment of debt / conversion of debt | |||||
| Amortization of deferred financing costs | |||||
| Amortization of debt premium | |||||
| Amortization of debt discount | |||||
| Share-based compensation | |||||
| Bad debt expense | |||||
| Change in fair value of warrant liabilities | |||||
| Loss on equity method investment | |||||
| Unrealized gain on equity securities | |||||
| Net unrealized loss (gain) on equity securities | |||||
| Gain on extinguishment of obligations | |||||
| Deferred taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Lease liability | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investment debt securities | |||||
| Sales and maturities of investment debt securities | |||||
| Purchases of fixed assets | |||||
| Sale of equity securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, net | |||||
| Payments of financing costs | |||||
| Proceeds from issuance of term debt | |||||
| Principal payments on secured term debt | |||||
| Proceeds from exercise of options | |||||
| Proceeds from issuance of ESPP shares | |||||
| Proceeds from exercise of warrants | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing activities: | |||||
| Beneficial conversion feature on convertible preferred stock | |||||
| Accretion of dividends on convertible preferred stock | |||||
| Convertible Preferred Stock | |||||
| Total accretion of dividends on convertible preferred stock | |||||
| Operating cash flows paid for amounts included in the measurement of lease liabilities | |||||
| Capitalized lease obligations | |||||
| Accounting Standards Update 2016-02 | |||||
| Total capitalized lease obligations | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Unpaid fixed asset additions | |||||
| Common stock issued upon conversion of convertible preferred stock | |||||
| Fair value of modification to lender warrants | |||||
| Cumulative effect of change in accounting principle | |||||
| Accounting Standards Update 2016-02 | |||||
| ASU 2014-09 | |||||
| Total cumulative effect of change in accounting principle | |||||
| Components of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted Cash | |||||
Loading...